Seegene Research and Development Center for Life Science is the core of the Seegene Inc., where development of all its innovative new technologies and products occurs. R&D center reflects unlimited potential growth of Seegene and allows continue to reinforce its capabilities in Molecular Diagnostics on global level. Seegene’s technology enables to detect multiple pathogens in a single reaction using Real-time PCR method. Seegene will continue to make a contribution to realize its dream of becoming the global leader in Molecular diagnostics via technology development in spirit of human respects and challenges
Seegene’s proprietary technologies ACP™ and DPO™ optimize the efficiency and accuracy of conventional PCR method which widely used for molecular diagnostics, to test different types of pathogens in a single reaction. In addition to that, Seegene has been developed its molecular diagnostic products to detect multiple target pathogens simultaneously in a single reaction using Real-time PCR based on its READ and TOCE™ Technologies, which overcome technical limitations of conventional Real-time PCR method.
Based on Seegene’s core technologies, Seegene focuses on developing various diagnostic products. Its molecular diagnostic products that can simultaneously detect multiple target pathogens, includes products for detecting causing pathogens of respiratory diseases, STDs, tuberculosis, meningitis, cervical cancer, sepsis, gastrointestinal diseases, as well as mutation or drug resistance test that can cause genetic diseases.
Seegene is actively engaged in exchanges with worlds’ leading molecular diagnostics companies. Seegehe is particularly focusing on developing a new customized molecular diagnosis automation system such as the practicalization of technology and the activities of commercializing products, along with many global diagnostic automation equipment companies.
Seegene is developing its exclusive results analysis software that integrates IT technology into the molecular diagnostics technologies for rapid and easy analysis of test results from Seegene’s high multiplex molecular diagnostic assays. Its own developed software not only enables to apply Seegene product to various real-time PCR instruments, but also provides quantitative and automated result analysis, interlocked with hospital database systems (such as LIS), and easier patient follow up management.
Starting with the development of OEM equipment for molecular diagnosis medical examinations, Seegene is now developing its own methods and designs of diagnosis instruments that include the Extraction instruments, PCR devices, PCR reagents, Auto electrophoresis detection equipment, and Real-time PCR instruments. Seegene also keep releasing exclusive systems that optimized for Seegene’s products through active partnership and development cooperation with global companies.
Based on years of expertise and experience in molecular diagnosis, Seegene now has the world-class diagnostic products in response to development requests from various experts around the world. As we know the importance of academic accumulation, Seegene strives to build a better research environment through continuous information analysis.
Seegene designs, develops, manufactures and services products according to requirements and processes of Quality Management Systems such as ISO9001:2015, ISO13485:2016, MDSAP. Also, we manufacture and maintain the international standard of quality control of products by registration of products in compliance to appropriate quality system requirements.
Seegene Inc,, which specializes in molecular diagnostics, is operating various customer support services such as the supporting various automation instruments set-ups, product demonstrations, confirmation tests, training for Seegene’s proprietary technologies and reagents, software and result analysis. Seegene strives to make high quality of the products that are safer and more convenient for customers.